Galleria mellonella
PulseAugur coverage of Galleria mellonella — every cluster mentioning Galleria mellonella across labs, papers, and developer communities, ranked by signal.
2 day(s) with sentiment data
-
Multi-cancer early detection tests face reimbursement uncertainty
The reimbursement for multi-cancer early detection tests remains uncertain, even with FDA approval. Experts and clinicians have raised concerns about the clear evidentiary benefit of these tests. This uncertainty could …
-
FDA urged to adopt new standards for multi-cancer early detection blood tests
The FDA is considering how to evaluate multi-cancer early detection (MCED) blood tests, such as GRAIL's Galleri test. These tests analyze blood for signals associated with numerous cancers, aiming to detect diseases ear…
-
Whoop removes subscription for health screenings amid market competition
Whoop has removed the subscription requirement for its Advanced Labs health screening feature, making blood tests accessible to all users. While the tests themselves still incur a cost starting at $150, this change aims…